InsiderClue
Insiders · Profile

Pizzie Nick

Chief Financial Officer at Axsome Therapeutics. Filing since 19 Jun 2018. CIK 0001742143

Company
Date
Role
Action
Shares
Amount
Of holding
AXSM Axsome Therapeutics, Inc.
9 Jun 2026
Chief Financial Officer
Sold on a plan
33,000
$7.92M
43.5%
AXSM Axsome Therapeutics, Inc.
22 Jan 2026
Chief Financial Officer
Sold on a plan
12,000
$2.26M
22.0%
AXSM Axsome Therapeutics, Inc.
14 Feb 2025
Chief Financial Officer
Sold on a plan
3,000
$393.21K
6.6%
AXSM Axsome Therapeutics, Inc.
13 Feb 2025
Chief Financial Officer
Sold on a plan
12,000
$1.56M
22.1%
AXSM Axsome Therapeutics, Inc.
18 Nov 2021
CHIEF FINANCIAL OFFICER
Bought
527
$18.71K
1.3%
AXSM Axsome Therapeutics, Inc.
18 Nov 2021
CHIEF FINANCIAL OFFICER
Bought
428
$14.97K
opened
AXSM Axsome Therapeutics, Inc.
29 Jun 2020
Chief Financial Officer
Bought
777
$59.55K
1.9%
AXSM Axsome Therapeutics, Inc.
26 Sep 2019
Chief Financial Officer
Bought
2,180
$54.06K
5.7%
AXSM Axsome Therapeutics, Inc.
11 Jun 2019
Chief Financial Officer
Bought
1,920
$39.94K
opened
AXSM Axsome Therapeutics, Inc.
19 Mar 2019
Chief Financial Officer
Bought
5,340
$67.18K
17.2%
AXSM Axsome Therapeutics, Inc.
19 Mar 2019
Chief Financial Officer
Bought
60
$761.40
opened
AXSM Axsome Therapeutics, Inc.
19 Jun 2018
Chief Financial Officer
Bought
31,000
$96.08K
opened
12 decisions on file.